The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1568
March 25, 2019
View Complete Issue         Table of Contents 2019 
Sulfonamide Cross-Reactivity
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Sulfonamide Cross-Reactivity
March 25, 2019 (Issue: 1568)
A reader has questioned why the label for the COX-2 selective NSAID celecoxib (Celebrex, and generics), which contains a sulfonamide moiety, states that it is contraindicated for use in patients with an allergy to sulfonamides, while the labels...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Sulfonamide Cross-Reactivity
Article code: 1568c
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.